Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
119,934,648
-
Total 13F shares
-
5,100,890
-
Share change
-
-1,316,243
-
Total reported value
-
$14,130,000
-
Put/Call ratio
-
279%
-
Price per share
-
$2.77
-
Number of holders
-
20
-
Value change
-
-$2,669,910
-
Number of buys
-
13
-
Number of sells
-
11
Institutional Holders of Tiziana Life Sciences Ltd - Common (TLSA) as of Q1 2021
As of 31 Mar 2021,
Tiziana Life Sciences Ltd - Common (TLSA) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,100,890 shares.
The largest 10 holders included
HighTower Advisors, LLC, MORGAN STANLEY, STATE STREET CORP, MARSHALL WACE, LLP, RENAISSANCE TECHNOLOGIES LLC, Orion Portfolio Solutions, LLC, Ausdal Financial Partners, Inc., Capital Asset Advisory Services LLC, WELLS FARGO & COMPANY/MN, and CITADEL ADVISORS LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.